{"id":"W4414018844","doi":"10.1002/cpdd.1586","title":"Safety and Pharmacokinetics of Long‐Acting Monoclonal Antibodies Tixagevimab and Cilgavimab (AZD7442) in a China Phase 2 Study and Evaluation of Asian Race Effect","year":2025,"lang":"en","type":"article","venue":"Clinical Pharmacology in Drug Development","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"AstraZeneca","keywords":"Pharmacokinetics; Medicine; Placebo; Adverse effect; Internal medicine; Randomized controlled trial; Gastroenterology; Pharmacology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002773614,0.0008466355,0.001311065,0.0003817364,0.0003234587,0.0004900068,0.0005357678,0.000744035,0.001731981],"category_scores_gemma":[0.0008544275,0.0006111276,0.001167999,0.0003381446,0.0008515895,0.0006864609,0.0002704817,0.001061514,0.0002063329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008742748,"about_ca_system_score_gemma":0.001635921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001441392,"about_ca_topic_score_gemma":0.00260017,"domain_scores_codex":[0.999402,0.0003310914,0.0000307137,0.00008530599,0.00007882324,0.0000719558],"domain_scores_gemma":[0.9994554,0.00008855257,0.0001995258,0.00004399098,0.00004579921,0.0001667029],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7155392,0.02440904,0.02867474,0.001017306,0.00258603,0.0002735277,0.0005725958,0.001570951,0.09236594,0.0003562918,0.001549062,0.1310854],"study_design_scores_gemma":[0.4325522,0.4601281,0.08510461,0.00004922017,0.002388139,0.0002983485,0.0001163302,0.003014255,0.01299433,0.000185339,0.003086602,0.00008264733],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975151,0.001424461,0.0002778556,0.0001031119,0.00002198467,0.0002690348,0.0000794709,0.00001942358,0.0002895771],"genre_scores_gemma":[0.99675,0.0008913798,0.0007530671,0.0002731711,0.00006187143,0.0004110066,0.0001923874,0.000007878193,0.0006592026],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002773614,"threshold_uncertainty_score":0.01466846,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04614544387618751,"score_gpt":0.4838551436213657,"score_spread":0.4377096997451782,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}